nodes	percent_of_prediction	percent_of_DWPC	metapath
Trilostane—ESR1—Alzheimer's disease	0.818	1	CbGaD
Trilostane—HSD3B1—cerebellum—Alzheimer's disease	0.00636	0.13	CbGeAlD
Trilostane—HSD3B2—nervous system—Alzheimer's disease	0.00536	0.11	CbGeAlD
Trilostane—HSD3B2—central nervous system—Alzheimer's disease	0.00516	0.106	CbGeAlD
Trilostane—ESR1—blood vessel—Alzheimer's disease	0.00418	0.0856	CbGeAlD
Trilostane—HSD3B2—brain—Alzheimer's disease	0.00409	0.0838	CbGeAlD
Trilostane—ESR2—forebrain—Alzheimer's disease	0.00322	0.0659	CbGeAlD
Trilostane—ESR2—telencephalon—Alzheimer's disease	0.00296	0.0606	CbGeAlD
Trilostane—ESR1—embryo—Alzheimer's disease	0.00249	0.051	CbGeAlD
Trilostane—ESR1—forebrain—Alzheimer's disease	0.00221	0.0451	CbGeAlD
Trilostane—Danazol—CCL2—Alzheimer's disease	0.00204	0.516	CrCbGaD
Trilostane—ESR1—telencephalon—Alzheimer's disease	0.00203	0.0415	CbGeAlD
Trilostane—ESR2—nervous system—Alzheimer's disease	0.00175	0.0358	CbGeAlD
Trilostane—ESR2—central nervous system—Alzheimer's disease	0.00168	0.0344	CbGeAlD
Trilostane—ESR2—cerebellum—Alzheimer's disease	0.00164	0.0337	CbGeAlD
Trilostane—ESR2—brain—Alzheimer's disease	0.00134	0.0273	CbGeAlD
Trilostane—ESR1—nervous system—Alzheimer's disease	0.0012	0.0245	CbGeAlD
Trilostane—ESR1—central nervous system—Alzheimer's disease	0.00115	0.0236	CbGeAlD
Trilostane—ESR1—cerebellum—Alzheimer's disease	0.00113	0.0231	CbGeAlD
Trilostane—ESR1—brain—Alzheimer's disease	0.000915	0.0187	CbGeAlD
Trilostane—Danazol—ESR1—Alzheimer's disease	0.000784	0.198	CrCbGaD
Trilostane—Estradiol—ESR1—Alzheimer's disease	0.000479	0.121	CrCbGaD
Trilostane—ESR1—Signaling mediated by p38-alpha and p38-beta—CREB1—Alzheimer's disease	0.000424	0.00328	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—APP—Alzheimer's disease	0.000419	0.00324	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—PSENEN—Alzheimer's disease	0.000415	0.00321	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	0.000415	0.00321	CbGpPWpGaD
Trilostane—ESR1—Validated nuclear estrogen receptor alpha network—SOD1—Alzheimer's disease	0.000413	0.0032	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—APH1A—Alzheimer's disease	0.000409	0.00317	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—CYP46A1—Alzheimer's disease	0.000409	0.00316	CbGpPWpGaD
Trilostane—Progesterone—ESR1—Alzheimer's disease	0.000406	0.103	CrCbGaD
Trilostane—ESR1—Nuclear Receptors—PPARG—Alzheimer's disease	0.000403	0.00312	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	0.000401	0.00311	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—NCSTN—Alzheimer's disease	0.000399	0.00309	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—ND1—Alzheimer's disease	0.000395	0.00306	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—PPARGC1A—Alzheimer's disease	0.000388	0.00301	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	0.000386	0.00299	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—GFAP—Alzheimer's disease	0.00038	0.00294	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—BDNF—Alzheimer's disease	0.000377	0.00292	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	0.000365	0.00283	CbGpPWpGaD
Trilostane—ESR1—LKB1 signaling events—GSK3B—Alzheimer's disease	0.000363	0.00281	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—IL1A—Alzheimer's disease	0.000362	0.0028	CbGpPWpGaD
Trilostane—ESR1—LKB1 signaling events—CREB1—Alzheimer's disease	0.00036	0.00279	CbGpPWpGaD
Trilostane—ESR1—Plasma membrane estrogen receptor signaling—IGF1—Alzheimer's disease	0.00036	0.00278	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	0.000353	0.00273	CbGpPWpGaD
Trilostane—ESR1—FOXA1 transcription factor network—INS—Alzheimer's disease	0.000351	0.00272	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—MEF2C—Alzheimer's disease	0.00035	0.00271	CbGpPWpGaD
Trilostane—HSD3B2—Corticotropin-releasing hormone—AKT1—Alzheimer's disease	0.000343	0.00266	CbGpPWpGaD
Trilostane—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—Alzheimer's disease	0.000338	0.00262	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—CHAT—Alzheimer's disease	0.000336	0.0026	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—TPI1—Alzheimer's disease	0.000336	0.0026	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	0.000335	0.00259	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—PLAU—Alzheimer's disease	0.00033	0.00255	CbGpPWpGaD
Trilostane—ESR1—Plasma membrane estrogen receptor signaling—NOS3—Alzheimer's disease	0.000326	0.00252	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—PSEN2—Alzheimer's disease	0.000324	0.00251	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—MAOB—Alzheimer's disease	0.000322	0.00249	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—BDNF—Alzheimer's disease	0.000321	0.00248	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	0.000319	0.00247	CbGpPWpGaD
Trilostane—ESR1—Nuclear Receptor transcription pathway—PPARG—Alzheimer's disease	0.000318	0.00246	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—BAX—Alzheimer's disease	0.000318	0.00246	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—GAPDH—Alzheimer's disease	0.00031	0.0024	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	0.000306	0.00237	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	0.000304	0.00235	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—PHF1—Alzheimer's disease	0.000304	0.00235	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	0.000303	0.00235	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—NOS2—Alzheimer's disease	0.000303	0.00235	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—A2M—Alzheimer's disease	0.000299	0.00232	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	0.000299	0.00231	CbGpPWpGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—MEF2C—Alzheimer's disease	0.000298	0.00231	CbGpPWpGaD
Trilostane—ESR2—Plasma membrane estrogen receptor signaling—AKT1—Alzheimer's disease	0.000297	0.0023	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—EIF2AK2—Alzheimer's disease	0.000294	0.00228	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—PLAU—Alzheimer's disease	0.000288	0.00223	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—CREB1—Alzheimer's disease	0.000279	0.00216	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—INS—Alzheimer's disease	0.000278	0.00215	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	0.000277	0.00214	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—MAPT—Alzheimer's disease	0.000272	0.00211	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—PTGS2—Alzheimer's disease	0.000272	0.00211	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—LEP—Alzheimer's disease	0.000268	0.00208	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	0.000267	0.00206	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—CST3—Alzheimer's disease	0.000264	0.00204	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—ACHE—Alzheimer's disease	0.00026	0.00201	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—GSK3A—Alzheimer's disease	0.000259	0.00201	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—GSK3A—Alzheimer's disease	0.000258	0.002	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—INPP5D—Alzheimer's disease	0.000257	0.00199	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	0.000255	0.00197	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—CHAT—Alzheimer's disease	0.000254	0.00197	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—TPI1—Alzheimer's disease	0.000254	0.00197	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—IAPP—Alzheimer's disease	0.000247	0.00191	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—ENO1—Alzheimer's disease	0.000244	0.00189	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—PTGS1—Alzheimer's disease	0.000244	0.00189	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—MAOB—Alzheimer's disease	0.000244	0.00189	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—CREB1—Alzheimer's disease	0.000244	0.00189	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—ACHE—Alzheimer's disease	0.000243	0.00188	CbGpPWpGaD
Trilostane—Progesterone—CYP2D6—Alzheimer's disease	0.000242	0.0612	CrCbGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—ESR1—Alzheimer's disease	0.000241	0.00186	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—CYP2D6—Alzheimer's disease	0.000239	0.00185	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—CCL2—Alzheimer's disease	0.000238	0.00185	CbGpPWpGaD
Trilostane—ESR1—Estrogen signaling pathway—AKT1—Alzheimer's disease	0.000238	0.00184	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—GAPDH—Alzheimer's disease	0.000235	0.00182	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—BCL2—Alzheimer's disease	0.000235	0.00182	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—GSK3B—Alzheimer's disease	0.000233	0.0018	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	0.000232	0.0018	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—CREB1—Alzheimer's disease	0.000231	0.00179	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	0.00023	0.00178	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—A2M—Alzheimer's disease	0.000227	0.00176	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—BCHE—Alzheimer's disease	0.000227	0.00176	CbGpPWpGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—CREB1—Alzheimer's disease	0.000217	0.00168	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	0.000217	0.00168	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—GSK3A—Alzheimer's disease	0.000215	0.00166	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—VEGFA—Alzheimer's disease	0.000214	0.00166	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—PLCB1—Alzheimer's disease	0.000214	0.00166	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—APP—Alzheimer's disease	0.000211	0.00164	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	0.00021	0.00162	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	0.000208	0.00161	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—ABCA1—Alzheimer's disease	0.000207	0.00161	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—S100B—Alzheimer's disease	0.000206	0.0016	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	0.000202	0.00156	CbGpPWpGaD
Trilostane—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—Alzheimer's disease	0.000201	0.00156	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—NOS3—Alzheimer's disease	0.000201	0.00156	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—ACHE—Alzheimer's disease	0.000197	0.00153	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—TFAM—Alzheimer's disease	0.000196	0.00152	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—INPP5D—Alzheimer's disease	0.000195	0.00151	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—MAPK8—Alzheimer's disease	0.00019	0.00147	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	0.000189	0.00146	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	0.000189	0.00146	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—ENO1—Alzheimer's disease	0.000185	0.00143	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PTGS1—Alzheimer's disease	0.000185	0.00143	CbGpPWpGaD
Trilostane—ESR1—Aryl Hydrocarbon Receptor—TNF—Alzheimer's disease	0.000184	0.00142	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	0.000182	0.00141	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—BAX—Alzheimer's disease	0.000182	0.00141	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—CYP2D6—Alzheimer's disease	0.000181	0.0014	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—PPARGC1A—Alzheimer's disease	0.000179	0.00138	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—HMOX1—Alzheimer's disease	0.000178	0.00138	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	0.000173	0.00134	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—BCHE—Alzheimer's disease	0.000172	0.00133	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—IL1B—Alzheimer's disease	0.000171	0.00132	CbGpPWpGaD
Trilostane—ESR1—LKB1 signaling events—TP53—Alzheimer's disease	0.000171	0.00132	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—LPL—Alzheimer's disease	0.000163	0.00126	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PLCB1—Alzheimer's disease	0.000162	0.00126	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—Alzheimer's disease	0.000162	0.00125	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	0.00016	0.00124	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	0.00016	0.00124	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	0.000159	0.00123	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—ABCA1—Alzheimer's disease	0.000157	0.00122	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—MAPK8—Alzheimer's disease	0.000157	0.00121	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—PHF1—Alzheimer's disease	0.000153	0.00119	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—BAX—Alzheimer's disease	0.000151	0.00117	CbGpPWpGaD
Trilostane—ESR1—Plasma membrane estrogen receptor signaling—AKT1—Alzheimer's disease	0.00015	0.00116	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	0.000147	0.00114	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—MTHFR—Alzheimer's disease	0.000147	0.00113	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—TGFB1—Alzheimer's disease	0.000144	0.00111	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—TGFB1—Alzheimer's disease	0.000141	0.00109	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	0.000137	0.00106	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—CALM1—Alzheimer's disease	0.000137	0.00106	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—APOE—Alzheimer's disease	0.000136	0.00106	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	0.000136	0.00105	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PPARGC1A—Alzheimer's disease	0.000135	0.00105	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—CAV1—Alzheimer's disease	0.000135	0.00105	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—HMOX1—Alzheimer's disease	0.000135	0.00104	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—GSK3B—Alzheimer's disease	0.000132	0.00102	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—CREB1—Alzheimer's disease	0.000132	0.00102	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—CREB1—Alzheimer's disease	0.000131	0.00101	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	0.000125	0.000967	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—LPL—Alzheimer's disease	0.000123	0.000955	CbGpPWpGaD
Trilostane—ESR1—ATF-2 transcription factor network—IL6—Alzheimer's disease	0.000121	0.00094	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—ESR1—Alzheimer's disease	0.00012	0.000925	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—PPARG—Alzheimer's disease	0.000119	0.00092	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—EIF2S1—Alzheimer's disease	0.000118	0.000912	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	0.000117	0.000902	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—INS—Alzheimer's disease	0.000117	0.000902	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—TP53—Alzheimer's disease	0.000116	0.000896	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—NOTCH1—Alzheimer's disease	0.000116	0.000894	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—MTHFR—Alzheimer's disease	0.000111	0.000859	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—BCL2—Alzheimer's disease	0.000111	0.000856	CbGpPWpGaD
Trilostane—ESR2—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	0.000111	0.000856	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	0.000109	0.000845	CbGpPWpGaD
Trilostane—ESR2—Generic Transcription Pathway—PPARG—Alzheimer's disease	0.000109	0.000844	CbGpPWpGaD
Trilostane—ESR1—AP-1 transcription factor network—IL6—Alzheimer's disease	0.000106	0.00082	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	0.000105	0.000813	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—CALM1—Alzheimer's disease	0.000104	0.000803	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—APOE—Alzheimer's disease	0.000103	0.0008	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	0.000103	0.000796	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—CAV1—Alzheimer's disease	0.000102	0.000793	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—NOS3—Alzheimer's disease	0.000102	0.000791	CbGpPWpGaD
Trilostane—ESR1—Regulation of Telomerase—AKT1—Alzheimer's disease	0.0001	0.000774	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—TFAM—Alzheimer's disease	9.87e-05	0.000764	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—CASP3—Alzheimer's disease	9.76e-05	0.000755	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—PTGS2—Alzheimer's disease	9.35e-05	0.000723	CbGpPWpGaD
Trilostane—ESR1—Leptin signaling pathway—AKT1—Alzheimer's disease	9.25e-05	0.000716	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	9.17e-05	0.00071	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PPARG—Alzheimer's disease	9e-05	0.000697	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—INS—Alzheimer's disease	8.83e-05	0.000684	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	8.71e-05	0.000674	CbGpPWpGaD
Trilostane—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—Alzheimer's disease	8.69e-05	0.000673	CbGpPWpGaD
Trilostane—ESR2—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	8.68e-05	0.000672	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—VEGFA—Alzheimer's disease	8.28e-05	0.000641	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—TTR—Alzheimer's disease	8.12e-05	0.000628	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	8.08e-05	0.000626	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—NOS3—Alzheimer's disease	7.74e-05	0.000599	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	7.43e-05	0.000575	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PYY—Alzheimer's disease	7.1e-05	0.000549	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—PTGS2—Alzheimer's disease	7.08e-05	0.000548	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	6.86e-05	0.000531	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	6.3e-05	0.000487	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—TP53—Alzheimer's disease	6.26e-05	0.000484	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CDK5—Alzheimer's disease	6.15e-05	0.000476	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—EIF2S1—Alzheimer's disease	5.94e-05	0.00046	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—HTR6—Alzheimer's disease	5.92e-05	0.000458	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	5.88e-05	0.000455	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—NOTCH1—Alzheimer's disease	5.83e-05	0.000451	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—ESR1—Alzheimer's disease	5.76e-05	0.000445	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—IL6—Alzheimer's disease	5.7e-05	0.000441	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—NOTCH1—Alzheimer's disease	5.56e-05	0.000431	CbGpPWpGaD
Trilostane—ESR1—Generic Transcription Pathway—PPARG—Alzheimer's disease	5.5e-05	0.000426	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PSENEN—Alzheimer's disease	5.38e-05	0.000416	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—APH1A—Alzheimer's disease	5.3e-05	0.00041	CbGpPWpGaD
Trilostane—ESR1—Integrated Breast Cancer Pathway—AKT1—Alzheimer's disease	5.28e-05	0.000409	CbGpPWpGaD
Trilostane—ESR1—Signaling by ERBB4—AKT1—Alzheimer's disease	5.25e-05	0.000407	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—PPARG—Alzheimer's disease	5.25e-05	0.000406	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	5.18e-05	0.000401	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—NCSTN—Alzheimer's disease	5.16e-05	0.0004	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—LRP1—Alzheimer's disease	5.04e-05	0.00039	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—GFAP—Alzheimer's disease	4.92e-05	0.000381	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—GAL—Alzheimer's disease	4.92e-05	0.000381	CbGpPWpGaD
Trilostane—HSD3B1—Metabolism—AKT1—Alzheimer's disease	4.7e-05	0.000364	CbGpPWpGaD
Trilostane—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	4.38e-05	0.000339	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—A2M—Alzheimer's disease	4.34e-05	0.000336	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PSEN2—Alzheimer's disease	4.2e-05	0.000325	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—NPY—Alzheimer's disease	3.86e-05	0.000299	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—IAPP—Alzheimer's disease	3.84e-05	0.000297	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CRH—Alzheimer's disease	3.73e-05	0.000289	CbGpPWpGaD
Trilostane—HSD3B2—Metabolism—AKT1—Alzheimer's disease	3.56e-05	0.000276	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—NPS—Alzheimer's disease	3.53e-05	0.000274	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PPP3CA—Alzheimer's disease	3.52e-05	0.000272	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PTK2B—Alzheimer's disease	3.47e-05	0.000268	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—GAB2—Alzheimer's disease	3.37e-05	0.000261	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—SST—Alzheimer's disease	3.37e-05	0.000261	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—NTRK2—Alzheimer's disease	3.37e-05	0.000261	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—GSK3A—Alzheimer's disease	3.34e-05	0.000259	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—APP—Alzheimer's disease	3.29e-05	0.000254	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PLCB1—Alzheimer's disease	3.1e-05	0.00024	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—NGFR—Alzheimer's disease	2.89e-05	0.000224	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—ADAM10—Alzheimer's disease	2.83e-05	0.000219	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—NOTCH1—Alzheimer's disease	2.81e-05	0.000217	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—S100B—Alzheimer's disease	2.67e-05	0.000207	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—PPARG—Alzheimer's disease	2.65e-05	0.000205	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—IGF2—Alzheimer's disease	2.54e-05	0.000197	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—IGF1R—Alzheimer's disease	2.46e-05	0.00019	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—LPL—Alzheimer's disease	2.36e-05	0.000183	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—MEF2C—Alzheimer's disease	2.34e-05	0.000181	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—PRKCG—Alzheimer's disease	2.29e-05	0.000177	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—NGF—Alzheimer's disease	2.23e-05	0.000173	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CCR5—Alzheimer's disease	2.17e-05	0.000168	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—HTR2A—Alzheimer's disease	2.13e-05	0.000165	CbGpPWpGaD
Trilostane—ESR2—Gene Expression—AKT1—Alzheimer's disease	2.08e-05	0.000161	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CALM1—Alzheimer's disease	1.98e-05	0.000154	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—LEP—Alzheimer's disease	1.98e-05	0.000153	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—APOE—Alzheimer's disease	1.98e-05	0.000153	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CAV1—Alzheimer's disease	1.96e-05	0.000152	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—F2—Alzheimer's disease	1.86e-05	0.000144	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—NOTCH1—Alzheimer's disease	1.82e-05	0.000141	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—GSK3B—Alzheimer's disease	1.71e-05	0.000132	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CREB1—Alzheimer's disease	1.7e-05	0.000131	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—INS—Alzheimer's disease	1.69e-05	0.000131	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CCL2—Alzheimer's disease	1.66e-05	0.000129	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—IGF1—Alzheimer's disease	1.63e-05	0.000126	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—NOS3—Alzheimer's disease	1.48e-05	0.000115	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—CASP3—Alzheimer's disease	1.26e-05	9.73e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—MAPK8—Alzheimer's disease	1.16e-05	8.94e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—VEGFA—Alzheimer's disease	1.07e-05	8.26e-05	CbGpPWpGaD
Trilostane—ESR1—Gene Expression—AKT1—Alzheimer's disease	1.05e-05	8.1e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—TGFB1—Alzheimer's disease	9.79e-06	7.58e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—TP53—Alzheimer's disease	8.06e-06	6.24e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—IL6—Alzheimer's disease	7.38e-06	5.71e-05	CbGpPWpGaD
Trilostane—ESR1—Signaling Pathways—AKT1—Alzheimer's disease	6.81e-06	5.27e-05	CbGpPWpGaD
